Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.6 | -0.5 | -0.7 | 0.2 | 0.0 | 0.0 | 0.0 | 1,699.2 |
| Revenue growth | -213.5% | -27.8% | -442.2% | -1557.1% | | | -100.0% | 19.8% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1,656.2 |
| Gross profit | 0.6 | -0.5 | -0.7 | 0.2 | 0.0 | 0.0 | 0.0 | 3,355.4 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | | 197.5% |
| Selling, general and administrative | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 660.8 |
| Research and development | | | | | | | | 180.8 |
| EBIT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4,016.2 |
| EBIT margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | | 236.4% |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -122.6 |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | | 0.0% |
| |
| Diluted EPS | | | | | | $0.00 | $0.00 | $0.00 |
| Shares outstanding (diluted) | | | | | | 683,225.8 | 683,549.3 | 685,344.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|